Markets

Diplomat Pharmacy Clears Technical Benchmark, Hitting 90-Plus RS Rating

Shutterstock photo

On Thursday, Diplomat Pharmacy ( DPLO ) earned an upgrade to its Relative Strength ( RS ) Rating , from 79 to 90.

[ibd-display-video id=2385970 width=50 float=left autostart=true] This unique rating identifies market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the trailing 52 weeks matches up against all other stocks in our database.

Over 100 years of market history reveals that the best stocks tend to have an RS Rating of over 80 as they launch their biggest runs.

Looking For Winning Stocks? Try This Simple Routine

Diplomat Pharmacy is now considered extended and out of buy range after clearing a 19.18 buy point in a first-stage cup without handle . See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.

In terms of top and bottom line numbers, the company has posted rising EPS growth in each of the last three reports. Revenue growth has been a different story, coming in at -5% in the latest report.

The company holds the No. 3 rank among its peers in the Medical-Services industry group. China Cord Blood ( CO ) is the No. 1-ranked stock within the group.

RELATED:

Which Stocks Are Showing Improved Technical Action?

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

RS CO

Other Topics

Stocks

Latest Markets Videos